Cargando…
Low Molecular Weight Opioid Peptide Esters Could be Developed as a New Class of Analgesics
Low molecular weight opioid peptide esters (OPE) could become a class of analgesics with different side effect profiles than current opiates. OPE may have sufficient plasma stability to cross the blood brain barrier (BBB), undergo ester hydrolysis and produce analgesia. OPE of dipeptides, tyr-pro an...
Autor principal: | Goldberg, Joel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153123/ https://www.ncbi.nlm.nih.gov/pubmed/21863129 http://dx.doi.org/10.4137/PMC.S6803 |
Ejemplares similares
-
Commercial Low Molecular Weight Heparins — Patent Ecosystem and Technology Paradigm for Quality Characterization
por: Iqbal, Zarina, et al.
Publicado: (2022) -
Chronic Opioid Therapy and Opioid Tolerance: A New Hypothesis
por: Goldberg, Joel S.
Publicado: (2013) -
Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls
por: Reynaert, Marie-Line, et al.
Publicado: (2019) -
Stereochemical Basis for a Unified Structure Activity Theory of Aromatic and Heterocyclic Rings in Selected Opioids and Opioid Peptides
por: Goldberg, Joel S.
Publicado: (2010) -
Subtypes in Patients Taking Prescribed Opioid Analgesics and Their Characteristics: A Latent Class Analysis
por: Rauschert, Christian, et al.
Publicado: (2022)